课题基金 / 基金详情

The clinical impact of next-generation sequencing on myeloid malignancies

The clinical impact of next-generation sequencing on myeloid malignancies
下一代测序对骨髓恶性肿瘤的临床影响
批准号：
440022
负责人：
Ferrone Christina
金额：
$7.65万
依托单位：
Queen's University (Kingston, Ontario)
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2020
资助国家：
加拿大
项目状态：
已结题
起止时间：
2020-11-01 至 2023-11-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=440022&lang=en
关键词：
Clonal Hematopoiesis Diagnosis/Prognosis/Treatment Etiology And Clonal Evolution Myeloid Malignancies Next-Generation Sequencing

项目摘要

项目成果

Ferrone Christina的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In recent years, the significance of genetic information in the diagnosis, screening, and treatment of myeloid (blood) cancers has become highly evident. The increasing impact of identifying genes associated with these cancers necessitates more comprehens
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Clinical Impact of Oncomine Myeloid Targeted DNA Sequencing Assay for Patients with Hematological Disorders
Validation and Clinical Impact of the Oncomine Myeloid Targeted DNA and RNA Ion Semiconductor Sequencing Assay